Eastern Europe / European union / Western Europe

Mereo BioPharma Provides Update on Lead Clinical Programs – GlobeNewswire

by Editor · January 12, 2025

Orbit Phase 3 study of setrusumab in osteogenesis imperfecta continuing to planned second interim analysis, expected in mid-2025 Alvelestat, …Read More